Financial News
Headline News about Mainz Biomed N.V. - Ordinary Shares
Via Benzinga
The Latest Analyst Ratings for Mainz Biomed
November 20, 2023
Via Benzinga
Via Benzinga
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Via Benzinga
Topics
Intellectual Property
Via Benzinga
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
February 01, 2024
Via Benzinga
Exposures
COVID-19
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
February 01, 2024
Via Benzinga
Topics
Death
Exposures
Death
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 05, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 16, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 14, 2023
Via Benzinga
Crude Oil Gains Over 1%; US Budget Deficit Narrows For October
November 13, 2023
Via Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
November 13, 2023
Via Benzinga
Dow Surges 100 Points; Tenax Therapeutics Shares Spike Higher
November 13, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Fall; Tyson Foods Posts Upbeat Earnings
November 13, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.